This acquisition enhances Herbalife and Cristiano Ronaldo’s shared mission to promote personalized nutrition and global wellness.
LOS ANGELES–(BUSINESS WIRE)– Herbalife Ltd. (NYSE: HLF), a leading health and wellness company, has announced its agreement to acquire specific assets from Bioniq, a UK-based company specializing in personalized supplements aimed at making health more attainable and actionable. This strategic move supports Herbalife’s goal of evolving into a data-driven health platform powered by technology.
This press release includes multimedia. View the full release here: https://www.businesswire.com/news/home/20260326423343/en/
Herbalife to Expand Its Personalized Nutritional Supplement Capabilities Through Planned Acquisition of Bioniq
“The future of health and wellness is increasingly personalized and driven by data,” remarked Herbalife’s Chief Executive Officer, Stephan Gratziani. “By merging Bioniq’s personalized supplement technology with Pro2col and leveraging our expansive distributor network, we can provide personalized wellness solutions on a global scale.”
Bioniq formulates personalized supplements using its patented product personalization engine, considering an individual’s health history and an extensive database of biomarkers. Their custom supplements cater to a wide audience, from everyday consumers to elite athletes, notably including Cristiano Ronaldo.
This acquisition will enhance Herbalife’s earlier purchases of Pro2col and Link BioSciences, enabling the company to broaden its offerings of personalized nutritional supplements in various delivery formats. The combination of Bioniq’s innovative solutions with Herbalife’s established manufacturing prowess will allow for wide-scale and rapid expansion in personalized nutrition.
“I founded Bioniq in 2019 with a vision to empower individuals to optimize their health through a scientifically-informed approach to nutrition, utilizing biomarker and lifestyle data,” said Vadim Fedotov, Founder and President of Bioniq. “I am thrilled to partner with Herbalife and tap into its extensive global distribution network and commitment to scaling wellness solutions.”
Cristiano Ronaldo, a long-standing global nutrition partner of Herbalife and a stakeholder in Bioniq, endorses Herbalife’s vision of making personalized nutritional supplements more widely available through its distributor network.
“Throughout my career, understanding biometrics and personalized nutrition has been essential for achieving my highest performance,” Ronaldo stated. “As a devoted user of both Herbalife and Bioniq, I can attest to the benefits of a tailored nutritional strategy for optimizing performance. I’m excited to see Bioniq’s offerings become a part of Herbalife’s commitment to helping individuals take control of their health, wellness, and performance.”
The acquisition is expected to finalize in the second quarter of 2026, pending standard closing conditions and regulatory approvals. The total purchase price of $55 million will be paid over five years, including an initial $10 million payment at closing. Additionally, the transaction includes contingent payments of up to $95 million based on future performance metrics.
Herbalife has also secured an option to acquire Bioniq LAB, which focuses on small molecules and peptides. This option affords Herbalife strategic flexibility to explore potential long-term opportunities in this sector with careful consideration for capital efficiency.
Consumers in select European countries and the United States can expect to access Bioniq’s personalized nutritional supplements through Herbalife independent distributors later this year, with plans for further market expansion to follow.
For additional details, please visit www.herbalife.com.
About Herbalife Ltd.
Founded in 1980, Herbalife (NYSE: HLF) is a leading health and wellness company that has transformed lives through its nutrition products and business opportunities for independent distributors. The company provides scientifically-backed products in over 90 markets, supported by entrepreneurial distributors who offer one-on-one coaching and foster a community that encourages healthier lifestyles and well-being.
For further information, visit https://ir.herbalife.com.
About Bioniq
Launched in 2019 in London, Bioniq is a leader in personalized supplement solutions, based on detailed questionnaires and blood test results. Operating on a global scale and utilizing a comprehensive personalized nutrition database, Bioniq has developed customized formulas for numerous users, addressing individual nutrient deficiencies with precision.
For more information, visit https://www.bioniq.com/.
Forward-Looking Statements
This release contains “forward-looking statements” as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than historical facts are considered “forward-looking,” including projections of earnings, revenue, management’s plans, and expectations about future conditions and performance.
Although we believe these forward-looking statements are reasonable, actual outcomes may differ significantly due to various factors. Our financial condition, operational results, and predictions are subject to change and are influenced by risks that are often beyond our control. Such factors include, but are not limited to:
- The effects of current global economic conditions, including inflation, adverse currency fluctuations, and trade tariffs, on our operations and those of our customers and supply chain.
- Our ability to attract and retain members.
- Our relationships with our members and their influence on our operations.
- Noncompliance issues related to laws and regulations by our employees or members.
- Negative publicity regarding our company or the direct-selling industry, affecting market confidence.
- Changes in consumer preferences and industry standards, particularly regarding sustainability and governance matters.
- The competitive landscape of our sector.
- Legal and regulatory challenges concerning our products and business practices.
- Compliance with the Consent Order with the Federal Trade Commission (FTC).
- Risks associated with international operations, particularly in China.
- Our ability to implement growth strategies and initiatives for personalized products.
- The effectiveness of technology initiatives we embark upon.
- Potential disruptions caused by disasters, wars, cybersecurity incidents, or pandemics.
- Challenges in sourcing and distributing raw materials for our products.
- Our reliance on information technology infrastructure and successful integration of emerging technologies.
- Compliance with data protection laws and risks of security breaches.
- Limitations on our ability to change our direct-selling model.
- Sufficient protection of our intellectual property.
- Product concentration risks.
- Potential loss of key management personnel.
- Risks related to integration of acquisitions.
- Financial covenants affecting our operational flexibility.
- Risks concerning our convertible notes.
- Uncertainties related to tax laws and regulations.
- Being incorporated in the Cayman Islands and related implications.
- Volatility in share price due to speculative trading.
More details regarding possible variances from forward-looking statements are available in the company’s SEC filings, including the Annual Report on Form 10-K for the fiscal year ending December 31, 2025. This includes comprehensive discussions of “Risk Factors” and financial performance analyses. Sustainability-related statements may also be based on evolving standards and assumptions that could change in the future.
Forward-looking statements in this release represent our views as of the date of the announcement. We are under no obligation to update or revise these statements based on new events or circumstances, except as required by law.
View the original version on businesswire.com: https://www.businesswire.com/news/home/20260326423343/en/
Media Contact:
Miguel Lopez-Najera
Director, Global Corporate Communications
miguellope@herbalife.com
Investor Contact:
Erin Banyas
Vice President, Head of Investor Relations
erinba@herbalife.com
Source: Herbalife Ltd.
Released Mar 26, 2026 • 6:30am EDT
